InsidersTradesSigma
Total declarations
Company
▲ Purchases (0 ops.)
▼ Sales (0 ops.)
Insider track record
Board DirectorDisclosed buys
0
Disclosed sells
0
T+90 hit rate
23%
T+90 mean return
-24.3%
Across 13 buy signals with a settled T+90 return. Return basis: close on the day after publication.
Signal history
Browse the detailed record of transactions filed by Urdea Michael S, Director. Director active across 1 company, notably Pressure Biosciences INC. In total, 15 disclosures have been recorded. Activity tracked since 28 May 2021. The latest transaction was filed on 27 September 2024 (J). Regulator: SEC (Form 4). All data is openly available.
Declarations15 total
14,429 shares@ US$0.0282.7% of flowCommon StockSEC:0001493152-24-038782:0
2,872 shares@ US$0.163.2% of flowCommon StockSEC:0001493152-24-011694:0
5,218 shares@ US$0.3613.0% of flowCommon StockSEC:0001493152-23-044248:0
1,725 shares@ US$0.637.6% of flowCommon StockSEC:0001493152-23-038076:0
796 shares@ US$0.874.8% of flowCommon StockSEC:0001493152-23-019698:0
836 shares@ US$1.398.0% of flowCommon StockSEC:0001493152-23-009323:0
760 shares@ US$1.246.7% of flowCommon StockSEC:0001493152-22-035055:0
600 shares@ US$1.697.4% of flowCommon StockSEC:0001493152-22-021001:0
531 shares@ US$1.910.013% mcap15.4% of flowCommon StockSEC:0001493152-22-017983:0
459 shares@ US$2.210.013% mcap15.4% of flowCommon StockSEC:0001493152-22-011903:0
403 shares@ US$2.510.013% mcap14.4% of flowCommon StockSEC:0001493152-22-005821:0
475 shares@ US$2.130.012% mcap14.1% of flowCommon StockSEC:0001493152-21-028977:0
475 shares@ US$2.136.6% of flowCommon StockSEC:0001493152-21-028977
487 shares@ US$2.080.012% mcap13.3% of flowCommon StockSEC:0001493152-21-013313:0
487 shares@ US$2.0813.3% of flowCommon StockSEC:0001493152-21-013313
15 of 15 declarations
About Urdea Michael S
Michael S. Urdea is a Board Member at Pressure BioSciences Inc. He plays a key role in corporate governance and the company's strategy. His experience in the life sciences sector allows him to provide valuable insights to the management of Pressure BioSciences.
